Quarterly report · Q2
2425.TEDINET S100S852
Period2023-04-01 → 2023-09-30
Filed2023-11-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥9.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥189m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥128m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥199m | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥476m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥125m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥185m | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥186m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥112m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥324m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥103m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥112m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥103m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥3.5bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥3.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.2bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥1.2bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.4bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.3bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.1bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.3bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.3bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥958m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥930m | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥218m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥443m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥104m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥37m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥36m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥8m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥93m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥152m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥100m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥29.44 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥23.22 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.36 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.26 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥13.21 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 65.6% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 66.0% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 64.7% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥323m |
| jpcrp040300-q2r_E05440-000Nursing Servicereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E05440-000Nursing Servicereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥3.5bn |
| jpcrp040300-q2r_E05440-000Nursing Servicereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥279m |
| jpcrp040300-q2r_E05440-000Othersreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05440-000Othersreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05440-000Othersreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥233m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥4.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥512m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥358m |
| jpcrp040300-q2r_E05440-000Nursing Servicereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E05440-000Nursing Servicereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥3.3bn |
| jpcrp040300-q2r_E05440-000Nursing Servicereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥255m |
| jpcrp040300-q2r_E05440-000Othersreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05440-000Othersreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥1.2bn |
| jpcrp040300-q2r_E05440-000Othersreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥231m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥486m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 465
| Item | Context | Value | Unit |
|---|---|---|---|
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes accounting treatments specific to quarterly financial statements quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |